Inside the telehealth-fueled GLP-1 alternative market Alex Hogan By Alex Hogan Nov. 26, 2024

https://www.statnews.com/2024/11/26/glp-1-drugs-compounding-pharmacies-wegovy-zepbound-shortages/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--FyiERitfnhlcqKqfzsoidelyh0SbJ4tctnGT64l-JzZu3zMwccclSlZH9oiU39kj3rmTCKmp8yoTWDNuEzwPDwlKEQA&_hsmi=335661306&utm_content=335661306&utm_source=hs_email pharma Video: Inside the market for GLP-1 copycats Alex Hogan/STAT If you’re reading this newsletter, you probably already know about the blockbuster GLP-1 drugs for weight loss. But if you’re fuzzy on what we mean when we write about the compounded versions often sold online, let me recommend the latest deep dive video from STAT’s Alex Hogan. Alex explains the loophole that lets certain pharmacies make generic versions of the name-brand drugs Ozempic and Wegovy due to a continued shortage. “We’ve not been here before,” compounding expert Scott Brunner told Alex. “And so it really is a rare instance that we find ourselves in when this drug with such incredible demand is in such severe shortage.” Watch the video.